Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,797
archived clinical trials in
Peripheral Vascular Disease

Study Of Costs Realized After Percutaneous Coronary intervenTion Employing Same Day Discharge
A Randomized Cost Minimization Analysis Comparing Same Day Discharge With Overnight Hospital Stay Following Elective and Low Risk Urgent Percutaneous Coronary Intervention.
Status: Enrolling
Updated:  3/20/2018
Saint Jospeh Mercy Health System, St. Joseph Mercy [Hospital] Ann Arbor, Cardiac Catheterization Laboratory
mi
from
Ypsilanti, MI
Study Of Costs Realized After Percutaneous Coronary intervenTion Employing Same Day Discharge
A Randomized Cost Minimization Analysis Comparing Same Day Discharge With Overnight Hospital Stay Following Elective and Low Risk Urgent Percutaneous Coronary Intervention.
Status: Enrolling
Updated: 3/20/2018
Saint Jospeh Mercy Health System, St. Joseph Mercy [Hospital] Ann Arbor, Cardiac Catheterization Laboratory
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
Ischemic Preconditioning as an Intervention to Improve Stroke Rehabilitation - Froedtert
Ischemic Preconditioning as an Intervention to Improve Stroke Rehabilitation
Status: Enrolling
Updated:  3/20/2018
Medical College of Wisconsin
mi
from
Milwaukee, WI
Ischemic Preconditioning as an Intervention to Improve Stroke Rehabilitation - Froedtert
Ischemic Preconditioning as an Intervention to Improve Stroke Rehabilitation
Status: Enrolling
Updated: 3/20/2018
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Application for Self-Monitoring of Cardiovascular Risk
Application for Self-Monitoring of Cardiovascular Risk
Status: Enrolling
Updated:  3/21/2018
The Mayo Clinic
mi
from
Rochester, MN
Application for Self-Monitoring of Cardiovascular Risk
Application for Self-Monitoring of Cardiovascular Risk
Status: Enrolling
Updated: 3/21/2018
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Contrast- Enhanced Whole-Heart Coronary MRA at 3.0T (Tesla)
Contrast- Enhanced Whole-Heart Coronary Magnetic Resonance Angiography (MRA) at 3.0T
Status: Enrolling
Updated:  3/21/2018
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Contrast- Enhanced Whole-Heart Coronary MRA at 3.0T (Tesla)
Contrast- Enhanced Whole-Heart Coronary Magnetic Resonance Angiography (MRA) at 3.0T
Status: Enrolling
Updated: 3/21/2018
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Impact of Vitamin D Supplementation on Cardiac Structure and Function
Vitamin D and Omega-3 Trial: Ancillary Study (VITAL-Echo) on the Impact of Vitamin D Supplementation on Cardiac Structure and Function
Status: Enrolling
Updated:  3/21/2018
Massachusetts General Hospital
mi
from
Boston, MA
Impact of Vitamin D Supplementation on Cardiac Structure and Function
Vitamin D and Omega-3 Trial: Ancillary Study (VITAL-Echo) on the Impact of Vitamin D Supplementation on Cardiac Structure and Function
Status: Enrolling
Updated: 3/21/2018
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Eggs as Part of a Healthy Breakfast
Eggs as Part of a Healthy Breakfast: Lack of Association With Heart Disease Risk
Status: Enrolling
Updated:  3/21/2018
University of Connecticut
mi
from
Storrs, CT
Eggs as Part of a Healthy Breakfast
Eggs as Part of a Healthy Breakfast: Lack of Association With Heart Disease Risk
Status: Enrolling
Updated: 3/21/2018
University of Connecticut
mi
from
Storrs, CT
Click here to add this to my saved trials
Evaluating the Risk of Cognitive Impairment After Surgical and Transcatheter Aortic Valve Replacement
Proposal for Collection of Patient Data to Aid in Design of an Observational Study (i.e. Preparatory to Research) Evaluating Risk of Cognitive Impairment After Surgical and Transcatheter Valve Replacement.
Status: Enrolling
Updated:  3/22/2018
Minneapolis VA Health Care System
mi
from
Minneapolis, MN
Evaluating the Risk of Cognitive Impairment After Surgical and Transcatheter Aortic Valve Replacement
Proposal for Collection of Patient Data to Aid in Design of an Observational Study (i.e. Preparatory to Research) Evaluating Risk of Cognitive Impairment After Surgical and Transcatheter Valve Replacement.
Status: Enrolling
Updated: 3/22/2018
Minneapolis VA Health Care System
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Evaluation of Energy Drinks on Electrocardiographic, Vascular and Hematologic Parameters in Healthy Volunteers
Evaluation of Energy Drink Consumption on Electrocardiographic, Vascular and Hematologic Parameters in Young Healthy Volunteers: A Randomized, Double Blind, Active-Controlled, Crossover Study
Status: Enrolling
Updated:  3/22/2018
David Grant Medical Center
mi
from
Travis Air Force Base, CA
Evaluation of Energy Drinks on Electrocardiographic, Vascular and Hematologic Parameters in Healthy Volunteers
Evaluation of Energy Drink Consumption on Electrocardiographic, Vascular and Hematologic Parameters in Young Healthy Volunteers: A Randomized, Double Blind, Active-Controlled, Crossover Study
Status: Enrolling
Updated: 3/22/2018
David Grant Medical Center
mi
from
Travis Air Force Base, CA
Click here to add this to my saved trials
Impact of Enhanced External Counterpulsation (EECP) on VO2 MAX
Impact of Enhanced External Counterpulsation (EECP) on VO2 MAX
Status: Enrolling
Updated:  3/23/2018
David Grant AF Medical Center
mi
from
Travis Air Force Base, CA
Impact of Enhanced External Counterpulsation (EECP) on VO2 MAX
Impact of Enhanced External Counterpulsation (EECP) on VO2 MAX
Status: Enrolling
Updated: 3/23/2018
David Grant AF Medical Center
mi
from
Travis Air Force Base, CA
Click here to add this to my saved trials
Efficacy of Coreg CR and Lisinopril on Markers for Cardiovascular Functional and Structural Disease
Efficacy of Coreg CR and Lisinopril on Markers for Cardiovascular Functional and Structural Disease. DETECT (DEtection and Treatment of Early Cardiovascular Disease Trial)
Status: Enrolling
Updated:  3/23/2018
University of Minnesota, Variety Club Research Center 102
mi
from
Minneapolis, MN
Efficacy of Coreg CR and Lisinopril on Markers for Cardiovascular Functional and Structural Disease
Efficacy of Coreg CR and Lisinopril on Markers for Cardiovascular Functional and Structural Disease. DETECT (DEtection and Treatment of Early Cardiovascular Disease Trial)
Status: Enrolling
Updated: 3/23/2018
University of Minnesota, Variety Club Research Center 102
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Genetic Risk and Health Coaching for Type 2 Diabetes and Coronary Heart Disease
Genetic Risk and Health Coaching for Type 2 Diabetes and Coronary Heart Disease
Status: Enrolling
Updated:  3/24/2018
David Grant Medical Center
mi
from
Fairfield, CA
Genetic Risk and Health Coaching for Type 2 Diabetes and Coronary Heart Disease
Genetic Risk and Health Coaching for Type 2 Diabetes and Coronary Heart Disease
Status: Enrolling
Updated: 3/24/2018
David Grant Medical Center
mi
from
Fairfield, CA
Click here to add this to my saved trials
The Oakland Men's Health Disparities Study
The Oakland Men's Health Disparities Study
Status: Enrolling
Updated:  3/26/2018
Barbershops / Fleamarkets
mi
from
Oakland, CA
The Oakland Men's Health Disparities Study
The Oakland Men's Health Disparities Study
Status: Enrolling
Updated: 3/26/2018
Barbershops / Fleamarkets
mi
from
Oakland, CA
Click here to add this to my saved trials
DASH Cloud: Using Digital Health to Improve Adherence to the DASH Diet Among Women
DASH Cloud: Using Digital Health to Improve Adherence to the DASH Diet Among Women at Risk for Cardiovascular Disease
Status: Enrolling
Updated:  3/27/2018
The Sarah W. Stedman Nutrition and Metabolism Center
mi
from
Durham, NC
DASH Cloud: Using Digital Health to Improve Adherence to the DASH Diet Among Women
DASH Cloud: Using Digital Health to Improve Adherence to the DASH Diet Among Women at Risk for Cardiovascular Disease
Status: Enrolling
Updated: 3/27/2018
The Sarah W. Stedman Nutrition and Metabolism Center
mi
from
Durham, NC
Click here to add this to my saved trials
The Association of SAA With Apolipoprotein B Affects Cardiovascular Risk
The Association of SAA With Apolipoprotein B Affects Cardiovascular Risk
Status: Enrolling
Updated:  3/27/2018
Va Medical Center
mi
from
Lexington, KY
The Association of SAA With Apolipoprotein B Affects Cardiovascular Risk
The Association of SAA With Apolipoprotein B Affects Cardiovascular Risk
Status: Enrolling
Updated: 3/27/2018
Va Medical Center
mi
from
Lexington, KY
Click here to add this to my saved trials
Treadmill Exercise and GM-CSF Study to Improving Functioning in Peripheral Artery Disease (PAD)
PROgenitor Cell Release Plus Exercise to Improve functionaL Performance in PAD: The PROPEL Study
Status: Enrolling
Updated:  3/28/2018
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Treadmill Exercise and GM-CSF Study to Improving Functioning in Peripheral Artery Disease (PAD)
PROgenitor Cell Release Plus Exercise to Improve functionaL Performance in PAD: The PROPEL Study
Status: Enrolling
Updated: 3/28/2018
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Click here to add this to my saved trials
Antiplatelet Therapy Guided by Thrombelastography in Patients With Acute Coronary Syndromes (TEGCOR Study)
Antiplatelet Therapy Guided by Thrombelastography in Patients With Acute Coronary Syndromes (TEGCOR Study)
Status: Enrolling
Updated:  3/28/2018
Eskenazi Health
mi
from
Indianapolis, IN
Antiplatelet Therapy Guided by Thrombelastography in Patients With Acute Coronary Syndromes (TEGCOR Study)
Antiplatelet Therapy Guided by Thrombelastography in Patients With Acute Coronary Syndromes (TEGCOR Study)
Status: Enrolling
Updated: 3/28/2018
Eskenazi Health
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Antiplatelet Therapy Guided by Thrombelastography in Patients With Acute Coronary Syndromes (TEGCOR Study)
Antiplatelet Therapy Guided by Thrombelastography in Patients With Acute Coronary Syndromes (TEGCOR Study)
Status: Enrolling
Updated:  3/28/2018
Indiana University Health Methodist Hospital
mi
from
Indianapolis, IN
Antiplatelet Therapy Guided by Thrombelastography in Patients With Acute Coronary Syndromes (TEGCOR Study)
Antiplatelet Therapy Guided by Thrombelastography in Patients With Acute Coronary Syndromes (TEGCOR Study)
Status: Enrolling
Updated: 3/28/2018
Indiana University Health Methodist Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
RESveratrol To Improve Outcomes in oldeR pEople With PAD (the RESTORE Trial)
RESveratrol To Improve Outcomes in oldeR pEople With PAD (the RESTORE Trial)
Status: Enrolling
Updated:  3/28/2018
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
RESveratrol To Improve Outcomes in oldeR pEople With PAD (the RESTORE Trial)
RESveratrol To Improve Outcomes in oldeR pEople With PAD (the RESTORE Trial)
Status: Enrolling
Updated: 3/28/2018
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Click here to add this to my saved trials
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT)
Status: Enrolling
Updated:  3/28/2018
Florida Hospital
mi
from
Orlando, FL
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT)
Status: Enrolling
Updated: 3/28/2018
Florida Hospital
mi
from
Orlando, FL
Click here to add this to my saved trials
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT)
Status: Enrolling
Updated:  3/28/2018
Emory University
mi
from
Atlanta, GA
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT)
Status: Enrolling
Updated: 3/28/2018
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT)
Status: Enrolling
Updated:  3/28/2018
UTHealth Science Center
mi
from
Houston, TX
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT)
Status: Enrolling
Updated: 3/28/2018
UTHealth Science Center
mi
from
Houston, TX
Click here to add this to my saved trials
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT)
Status: Enrolling
Updated:  3/28/2018
Stanford Univ Med Ctr
mi
from
Stanford, CA
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT)
Status: Enrolling
Updated: 3/28/2018
Stanford Univ Med Ctr
mi
from
Stanford, CA
Click here to add this to my saved trials
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT)
Status: Enrolling
Updated:  3/28/2018
WellStar Health System
mi
from
Marietta, GA
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT)
Status: Enrolling
Updated: 3/28/2018
WellStar Health System
mi
from
Marietta, GA
Click here to add this to my saved trials
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT)
Status: Enrolling
Updated:  3/28/2018
University of Kansas Medical Center
mi
from
Kansas City, KA
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT)
Status: Enrolling
Updated: 3/28/2018
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT)
Status: Enrolling
Updated:  3/28/2018
St. Louis University
mi
from
Saint Louis, MO
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT)
Status: Enrolling
Updated: 3/28/2018
St. Louis University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT)
Status: Enrolling
Updated:  3/28/2018
Riverside Methodist Hospital
mi
from
Columbus, OH
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT)
Status: Enrolling
Updated: 3/28/2018
Riverside Methodist Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT)
Status: Enrolling
Updated:  3/28/2018
Valley Baptist Medical Center
mi
from
Harlingen, TX
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke
Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT)
Status: Enrolling
Updated: 3/28/2018
Valley Baptist Medical Center
mi
from
Harlingen, TX
Click here to add this to my saved trials
Vascular Risk After Kidney Transplantation
Vascular Risk After Kidney Transplantation
Status: Enrolling
Updated:  3/29/2018
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Vascular Risk After Kidney Transplantation
Vascular Risk After Kidney Transplantation
Status: Enrolling
Updated: 3/29/2018
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
Home-based vs. Supervised Exercise for People With Claudication
Home-based vs. Supervised Exercise for Claudicants
Status: Enrolling
Updated:  3/30/2018
General Clinical Research Center, University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
Home-based vs. Supervised Exercise for People With Claudication
Home-based vs. Supervised Exercise for Claudicants
Status: Enrolling
Updated: 3/30/2018
General Clinical Research Center, University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Functional Outcomes of Stay Strong Stay Healthy Program
Functional Outcomes of Stay Strong, Stay Healthy Program
Status: Enrolling
Updated:  4/2/2018
University Of Missouri-Columbia
mi
from
Columbia, MO
Functional Outcomes of Stay Strong Stay Healthy Program
Functional Outcomes of Stay Strong, Stay Healthy Program
Status: Enrolling
Updated: 4/2/2018
University Of Missouri-Columbia
mi
from
Columbia, MO
Click here to add this to my saved trials
Longitudinal Study in Perimenopausal Women With Risk Factors for Atherosclerosis
Iron and Atherosclerosis: Longitudinal Study in Perimenopausal Women With Risk Factors for Atherosclerosis
Status: Enrolling
Updated:  4/3/2018
The Ohio State Univeristy Medical Center
mi
from
Columbus, OH
Longitudinal Study in Perimenopausal Women With Risk Factors for Atherosclerosis
Iron and Atherosclerosis: Longitudinal Study in Perimenopausal Women With Risk Factors for Atherosclerosis
Status: Enrolling
Updated: 4/3/2018
The Ohio State Univeristy Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
University of Alabama at Birmingham
mi
from
Birmingham, AL
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
University of Alabama at Birmingham
mi
from
Birmingham, AL
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Saadat Ansari MD LLC
mi
from
Huntsville, AL
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Saadat Ansari MD LLC
mi
from
Huntsville, AL
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
University of South Alabama Division of Clinical Research
mi
from
Mobile, AL
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
University of South Alabama Division of Clinical Research
mi
from
Mobile, AL
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Heart Vascular of Northern Arizona
mi
from
COttonwood, AZ
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Heart Vascular of Northern Arizona
mi
from
COttonwood, AZ
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Cardiovascular Associates of Mesa
mi
from
Mesa, AZ
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Cardiovascular Associates of Mesa
mi
from
Mesa, AZ
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Arizona Arthritis & Rheumatology Research PLLC
mi
from
Phoenix, AZ
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Arizona Arthritis & Rheumatology Research PLLC
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Scottsdale Medical Imaging, Ltd
mi
from
Scottsdale, AZ
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Scottsdale Medical Imaging, Ltd
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
The Heart Clinic
mi
from
Scottsdale, AZ
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
The Heart Clinic
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Pima Heart
mi
from
Tucson, AZ
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Pima Heart
mi
from
Tucson, AZ
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Southern Arizona VA Health Care System
mi
from
Tucson, AZ
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Southern Arizona VA Health Care System
mi
from
Tucson, AZ
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Arkansas Cardiology, PA
mi
from
Little Rock, AR
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Arkansas Cardiology, PA
mi
from
Little Rock, AR
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Arkansas Heart Hospital
mi
from
Little Rock, AR
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Arkansas Heart Hospital
mi
from
Little Rock, AR
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Medical Group of Culver City
mi
from
Culver City, CA
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Medical Group of Culver City
mi
from
Culver City, CA
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Touro University California- Solano County Affiliated Clinics
mi
from
Fairfield, CA
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Touro University California- Solano County Affiliated Clinics
mi
from
Fairfield, CA
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
University California San Francisco
mi
from
Fresno, CA
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
University California San Francisco
mi
from
Fresno, CA
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
UCSD Sulpizio Cardiovascular Center
mi
from
La Jolla, CA
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
UCSD Sulpizio Cardiovascular Center
mi
from
La Jolla, CA
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
The University of California, San Diego
mi
from
La Jolla, CA
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
The University of California, San Diego
mi
from
La Jolla, CA
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Kumar Medical Corporation
mi
from
Lancaster, CA
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Kumar Medical Corporation
mi
from
Lancaster, CA
Click here to add this to my saved trials